Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yeah it is...
Did anyone catch this at all???
Arthritis Advisory Committee Meeting
December 20, 2012
The other clinical trials in the Ampligen program are all open-
label and uncontrolled clinical trials and thus are not appropriate for assessment of efficacy or use a different dosing regimen (AMP-502T). The design of the placebo controlled trials
will be discussed in detail and the design of the uncontrolled clinical trials will not be described further.
Nothing like beating an ole horse. But listen to.
:03 to :06 of this youtube then
Now I wonder what he is up to ...
https://twitter.com/cosm_ed/following
Zero again Zero idea if this is this firms Ed or not..
But still keeping an eye on this..
Also very tragic what happened to Tony Scott.
His Films were always full of action and adventure.
Now take some of the profits from here not a lot just a % and put them into the last company that was in the PR. It is trading
at .021.. Some might call it a speculative buy.. I call it a long term value play. But the partnership and the long term sector change is well worth taking a serious look.
Congrats on those who held firm.
Merry Christmas.
Pilot
Ta-DA
This is what folks can look forward to in clinical trails
from others.
Not kidding you can look it up...
Efficacy and Safety of Fermented Velvet Antler Extract
Chonbuk
use those as search terms. OK.
Another Videotelephone-delivered Cognitive Behavioral Stress Management intervention..
Another.. Activity pacing
Another.. sodium oxybate
Another,, Acupuncture
nutraceutical supplements-http://en.wikipedia.org/wiki/Nutraceutical
Another,,Rituximab
Kinda makes one think about those people who spoke at the meeting
and why they have so much passion for this firm.
Don't you think..
Anyway.
Have a Merry Christmas
Pilot
The Positive Safety Profile Vote..
safety profile for new drugs that come on the market is never totally defined because new drugs are studied only in relatively small patient populations. The complete safety profile of a new drug will be defined only after it has been approved and is in use on the market."
FDA is charged with protecting our safety, a reasonable person would assume that the FDA is closely monitoring the effects of these drugs in their real tests on the public.
This Drug is Unique in it's makeup a one of a kind 2x strand RNA..
Of course the FDA is going to take steps to cover each and every
outcome.. The call for more data and the desire of the FDA to follow up on this is a very good thing.
The last 20 min of the panel discussion was very telling in
how the FDA is most likely going to proceed with this Drug.
They may even have to establish partnership so to speak
with HEB to help guide them through the published and not
published results. As for the press from HEB today that is just
a hey we are still here and this is the results of the panel.
I figure they will be taking the weekend and Christmas Vacation time to formulate a plan. Someone asked if they are Ripe for a buyout. I think that is a good assumption.. they have a good asset base and patents that have value. They also have a people walking around who have taken the drug who are living a better life because of it. Without the drug these very same people could very well be regulated back into a life of pain and suffering and seeking any kind of relief from that pain. And one panel member saw that all to clear. I think also the FDA is going to be spending some serious time working on a solution to this drug.
The FDA has the right connections and knowledge to help this firm. I believe they will do so . If not this panel and the FDA will be known in the media as the Death Panel. And that would not be a good thing for them.
Have a good weekend
Pilot
Yes we do.. :)
See your doing the patent thing. I found a list long time ago.
Tying to remember where it was. Needless to say this is
turning out to be a Patent Play and I hate using that term.
But the patents are very solid and the firm that reps mmrg
is of such a high standard it amazes me that more people
have not taken time to follow up on it.
I like the way MMRG is approaching the different firms who are
in violation and just working with them to make a fair and equitable agreement.
This to me is so much better than running in with Guns a blazing and demanding such and such.
Doing it this way can turn into a long term revenue stream.
And I like that. And I think others are taking note of that fact.
Anyway I am doing a lot of reading and the such.
Pilot.
Merry Christmas to you all.
A step towards digital doctoring "doctors on demand" virtual visits getting reimbursed http://on.wsj.com/TddSDq
Just saying:)
$HEB
Shares Outstanding 151.01 M
Number of Shares Shorted 4.17 M
Cash and Equivalents 25.06 M
Total Debt 5.87 M
Working Capital 26.66 M
Current Asset 36.45 M
Current Asset=Cash+Deposits+Liquid Assets=36.45 M
Current Asset is all of company's assets that can be used to pay off current liabilities within current fiscal period or over next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Assets
Current Assets-Current Liabilities= 26.66 M
Cash or Cash Equivalents 25.06 M are the most liquid of all assets found on company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Note I did not come up with these numbers on my own it came from a fundamentals website. so check those numbers.
Pilot
Look at this and answer the answer is in it.
date time price ask bid
12/21/12 11:15:55 0.2796 0.2758 0.2796 12678371
No really I think that is very much in play at this point and time.
Just put this over on yahoo and will put it here also.
And will add a little more..
I did one trade today I bought..
I was able to listen in on the meeting from about speaker 25 or there about. I was stunned, my heart was broken for the speakers. Then to watch the vote from the panel even though it was a no yes no type of deal. I took out of the meeting a feeling that the panel really wanted to approve the meds but just due to the manner the science was presented it was not able to. And what was clear and I posted a snap shot of the comment direct from the meeting was this.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=82678536
"Everyone is interested in developing for the patients with CFS, The FDA is VERY interested in this. We are open to sponsors. I think we have comments from the office level.
This is far from over from what I was able to hear today. The term conditional approval was brought out in the meeting, and I even used the term in some of my post based on what I had heard. But digging a little deeper and I am no expert there are more paths that can be taken
and conditional approval is for devices not meds. One can look for Fast Track,
Accelerated Approval,Priority Review. these are the processes that this firm can take.
From the comments of the panel today I feel one of these will be taken.
But also from the panel comments I think the FDA is going to be all over this firm
I think the speakers today struck a cord in the panels heart and they were pissed that
this firm did not fill in the blanks in a orderly manner. So there you go. This is far from over.
imho.
Pilot
Hey I am the out of nowhere poster and after market I took my first position based on what I heard today.
Not a huge one but enough to keep me aware of it.
I was able to snapshot one more pic from the meeting that I think is important.
and if anyone has any idea what "Package" is please update.
ON that statement is when I took my position.. I will shut the ___ up now and again sorry for sticking my nose in on your board.
Pilot
Donna Young ?@ScripDonnaDC
#FDA's Michele closes $HEB Ampligen meeting with: FDA is very interested in more development for CFS treatments #biotech #pharma
This is going to be in the bank soon enough from what I heard today.
This firm got the tail ran over for sloppy work and the way they
did things. This is not over by a long shot. I think the panel discussion was pretty clear they want more data ..
The public speakers today was a clear indication to the panel that
this drug worked for them ... now to me it is a matter of this firm
shoring up it's research team with paper pushers who know how to crunch the data and present it in a pretty pac. to the bean heads over in the FDA and you all know the type form school days.
the ones who just freaked out it they did not have every dot over an I or a T crossed. The package the fellow said he had at the end
was not followed up on at all. hummm will be watching this one for some time.
Pilot
Panel want more test and further study.
I still stick with a conditional approval
on a condition of a well done study.
Safety question 4 yes 9 no two no vote. Sad indeed.
feel sorry for those poor people who spoke today.
No Position again. Anyway I see conditional approval which puts you all back in the same boat I guess. That lady on the panel tone was very aggressive and negative against the whole process.
But then you have people who need it who stated it worked for them
So what can they do. again not approving or helping getting it approved is just wrong. good luck. to you all sorry for sticking my nose in on your board. I was just amazed they did not stop trading on this while the panel was up and running. I think that was a first. ??
Pilot
Missed the last 2 min what happend..
Nooooo
Fraud shoddy, some female speaker now.
here it is..
Donna Young ?@ScripDonnaDC
Deception or fraud with $HEB's Ampligen data? #FDA official: We don't like to go there ... but eyebrows are raised #biotech #pharma
NO POSITION YET
LOL I hear you, There is no such thing as a fair market. that is
for sure
Some will like this tweet..
"I never see patient's testimony is so unanimously contradictory with FDA's analysis. What panel member think?"
From what I am hearing folks want it. did not get the FDA side at all watching the chart and trades it is in the .40 area but trading super fast so figure it is computer trading..
Lot of Doctors in favor on the speaker list..
speakers are done taking a break.. then public comments then committee..
So should know something soon
I just found this from twitter but am trying to listen to the speakers. From what I am hearing from these folks non approval is
equal to murder by the FDA.. NO Position as of yet.
Whow.
China's top refiner Sinopec Group has acquired a 49 percent stake in the UK subsidiary of the Canada-based Talisman Energy Inc for USD 1.5 billion, marking the first direct investment by a Chinese company in the North Sea, the state-run China Daily reported Wednesday.
Yes kinda cool
So how many of you all are going to go watch this one..
http://ghostexchangemovie.com/videos/watch-the-trailer/
I plan to..
royalty agreements are just part of this picture.
the bio side is valid and has produced income.
and the firm that is on that is making positive strides each
quarter. see post post this week on that.
The partnership are serious as three posted a few ago.
There is a heck of a lot of things that are putting this
firm back on track.
And that is just how it sit.
What you call hype is based on the facts of the patents in place.
There is no hype to that there is a law firm that is active
in the actions. As we can tell by the pr'ed firm/s coming to the table. One of which has what was it 30thousand doctors in the network. That is why so many folks took starter positions in the last couple of weeks. The chart show a pretty darn clear picture on the lower indications that they not only got in they are staying in.
Not on hype alone. trust me the day trader crews know where to put profits and let them ride. And many according to the acc/dis have done that here. the sideways movement with the peaks and valley is a good thing for everyone. It gives them time to read and understand the true upside of this firm.
There are firms who are sitting on patents who don't have a active
product who are winning case after case on patent claims. So much so that the government is taking a hard look at the way the law stands. How much more can I ask for with this firm to have valid patent claims and a product that is active and producing income??
Each and every firm that is in violation of those patents and have a product and are making money. Affect me and my stock and my income. therefore if those firms do not come to the table with mmrg I would think it would be well withing the rights of the share holders to demand compensation from the firms who are in violation. (just a thought)
Thanks Three good info.
here is a good link also .
More than a third of American adults think self-monitoring is the key to living a longer life, according to a survey commissioned by Philips Healthcare and conducted by Opinion Research Corporation.
http://mobihealthnews.com/19552/some-trust-mobile-health-tools-doctors-equally/
The tire debate, not from investors but tire folks.
hummm
http://forums.evolutionm.net/evo-tires-wheels-brakes-suspension-sponsored-tire-rack/507222-camber-tire.html
MedicalQuack ?@MedicalQuack
Interesting, another #EHR vendor pays MMRGlobal licensing fees for #PHR related #patent violations http://bit.ly/TwzXwx
If this ever gets off the chill this is going to run very hard and fast. I think..
New Tweet out..
The Institute for Health conference In Beverly Hills 2012 & A Visit to MMRGlobal Discussing MMR Pro Systems http://ducknetweb.blogspot.com/2012/11/the-institute-for-health-conference-in.html …
Old info never mind
More than 30,000 physician accounts belonging to one of the licensees.
Was busy today so did not see this info..
This is Great thanks for posting.
In reality there are not that many ehr/phr vendors in play...
Sure it seems like a lot but if one was to take the overall
doctor office count. hospital count there is a very itty bitty
amount of folks who are providing this service.
Thanks
Pilot
On another front
Celgene has issued figures which it says demonstrate the clinical value of the NICE-agreed patient access scheme for its cancer drug Revlimid
http://www.pharmafile.com/news/176412/revlimid-patient-scheme-working?utm_source=dlvr.it&utm_medium=twitter
and this
http://www.news-medical.net/news/20121211/Celgene-announces-results-from-REVLIMID-plus-VIDAZA-phase-II-study-on-AML.aspx
and this
http://www.bloomberg.com/news/2012-12-11/celgene-s-pomalidomide-helps-in-myeloma-after-others-fail.html
Hey biotech side of the board where does the mmrg stuff fit in/??
Well Look here..
EVault, A Seagate Company, Announces Partnership With Fujitsu
http://ih.advfn.com/p.php?pid=nmona&article=55484696
I hope someone calls Bob and point him to this. Re.. Seagate is our last 10Q and Now they are doing this.
Is there a connection>> ???
I am going to be busy so can not call sorry.
Pilot